Humacyte (HUMA) Earnings Date, Estimates & Call Transcripts $1.31 -0.10 (-7.09%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$1.31 0.00 (0.00%) As of 05/2/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Humacyte Earnings Summary Upcoming Earnings DateMay. 9Before Market OpensEstimatedConsensus EPS (Mar. 28) -$0.23 Actual EPS (Mar. 28) -$0.16 Beat By $0.07 Actual Revenue (Mar. 28) $7.23MHumacyte announced Q4 2024 earnings on March 28, 2025, reporting an EPS of -$0.16, which topped the consensus estimate of -$0.23 by $0.07. Quarterly revenue was reported to be $7.23 million, above analysts' expectations of $0.64 million. With a trailing EPS of -$1.26, Humacyte's earnings are expected to grow next year, from ($1.27) to ($0.83) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)HUMA Upcoming EarningsHumacyte's Q1 2025 earnings is scheduled for Friday, May 9, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Humacyte Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Humacyte and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHUMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HUMA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Humacyte Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.27) EPSNext Year EPS Consensus Estimate ($0.83) EPS Humacyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/9/2025(Estimated)-------3/28/2025Q4 2024-$0.23-$0.16+$0.07-$0.16$0.64M$7.23M11/8/2024Q3 2024-$0.25-$0.33 -$0.08-$0.33--8/13/2024Q2 2024-$0.23-$0.27 -$0.04-$0.06--5/10/2024Q1 2024-$0.23-$0.29 -$0.06-$0.29--3/22/2024Q4 2023-$0.25-$0.24+$0.01-$0.24$0.10M-11/9/2023Q3 2023-$0.25-$0.25--$0.25--8/14/2023Q2 2023-$0.22-$0.22--$0.22$0.10M-5/12/2023Q1 2023-$0.22-$0.22--$0.08-- Humacyte Earnings - Frequently Asked Questions When is Humacyte's earnings date? Humacyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based off last year's report dates. Learn more on HUMA's earnings history. Did Humacyte beat their earnings estimates last quarter? In the previous quarter, Humacyte (NASDAQ:HUMA) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.07. Learn more on analysts' earnings estimate vs. HUMA's actual earnings. How can I listen to Humacyte's earnings conference call? The conference call for Humacyte's latest earnings report can be listened to online. Listen to Conference Call How can I read Humacyte's conference call transcript? The conference call transcript for Humacyte's latest earnings report can be read online. Read Transcript How much revenue does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded annual revenue of $1.57 million. How much profit does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded net income of -$110.78 million. HUMA has generated -$1.26 earnings per share over the last four quarters. What is Humacyte's EPS forecast for next year? Humacyte's earnings are expected to grow from ($1.27) per share to ($0.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Zymeworks Earnings Pharvaris Earnings Spyre Therapeutics Earnings Mineralys Therapeutics Earnings Intellia Therapeutics Earnings Nurix Therapeutics Earnings Gyre Therapeutics Earnings Arcus Biosciences Earnings Collegium Pharmaceutical Earnings Avadel Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:HUMA) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HUMA Stock Free HUMA Stock Alerts